Estrogens promote invasion of prostate cancer cells in a paracrine manner through up-regulation of matrix metalloproteinase 2 in prostatic stromal cells

Endocrinology

Volumn 152, Issue 3, 2011, Pages 773-781

  Yu, Lin ^a   Wang, Chun Yu ^a   Shi, Jiandang ^a   Miao, Lin ^a   Du, Xiaoling ^c   Mayer, Doris ^b   Zhang, Ju ^a  

^a NANKAI UNIVERSITY   (China)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; GELATINASE A; MESSENGER RNA; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER CELL; CANCER INVASION; HUMAN; HUMAN CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; STROMA CELL; UPREGULATION;

CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; ESTRADIOL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; PARACRINE COMMUNICATION; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, ESTRADIOL; STROMAL CELLS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79951867608     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-1239     Document Type: Article

References (40)

1. Jemal A, Siegel R, Xu J, Ward E 2010 Cancer Statistics, 2010. CA Cancer J Clin 60:277-300
2. Devlin HL, Mudryj M 2009 Progression of prostate cancer: multiple pathways to androgen independence. Cancer Lett 274:177-186
3. Bogdanos J, Karamanolakis D, Tenta R, Tsintavis A, Milathianakis C, Mitsiades C, Koutsilieris M 2003 Endocrine/paracrine/autocrine survival factor activity of bone microenvironment participates in the development of androgen ablation and chemotherapy refractoriness of prostate cancer metastasis in skeleton. Endocr Relat Cancer 10: 279-289 (Pubitemid 36758654)
4. Vindrieux D, Escobar P, Lazennec G 2009 Emerging roles of chemokines in prostate cancer. Endocr Relat Cancer 16:663-673
5. Rennebeck G, Martelli M, Kyprianou N 2005 Anoikis and survival connections in the tumor microenvironment: is there a role in prostate cancer metastasis? Cancer Res 65:11230-11235
6. Ho SM, Leung YK, Chung I 2006 Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer. Ann NY Acad Sci 1089:177-193 (Pubitemid 47092060)
7. Wang Y, Hayward SW, Donjacour AA, Young P, Jacks T, Sage J, Dahiya R, Cardiff RD, Day ML, Cunha GR 2000 Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue. Cancer Res 60:6008-6017
8. Ricke WA, Ishii K, Ricke EA, Simko J, Wang Y, Hayward SW, Cunha GR 2006 Steroid hormones stimulate human prostate cancer progression and metastasis. Int J Cancer 118:2123-2131
9. Ricke WA, McPherson SJ, Bianco JJ, Cunha GR, Wang Y, Risbridger GP 2008 Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling. FASEB J 22:1512-1520 (Pubitemid 351656791)
10. El Touny LH, Banerjee PP 2009 Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis. Cancer Res 69:3695-3703
11. Niu YN, Xia SJ 2009 Stroma-epithelium crosstalk in prostate cancer. Asian J Androl 11:28-35
12. Thalmann GN, Rhee H, Sikes RA, Pathak S, Multani A, Zhau HE, Marshall FF, Chung LW 2009 Human prostate fibroblasts induce growth and confer castration resistance and metastatic potential in LNCaP cells. Eur Urol 58:162-171
13. Sung SY, Hsieh CL, Law A, Zhau HE, Pathak S, Multani AS, Lim S, Coleman IM, Wu LC, Figg WD, Dahut WL, Nelson P, Lee JK, Amin MB, Lyles R, Johnstone PA, Marshall FF, Chung LW 2008 Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis. Cancer Res 68:9996-10003
14. Tuxhorn JA, Ayala GE, Rowley DR 2001 Reactive stroma in prostate cancer progression. J Urol 166:2472-2483 (Pubitemid 33065339)
15. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR 1999 Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59:5002-5011 (Pubitemid 29472907)
16. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, RowleyDR 2002 Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 8:2912-2923 (Pubitemid 35025739)
17. Kuniyasu H, Ukai R, Johnston D, Troncoso P, Fidler IJ, Pettaway CA 2003 The relative mRNA expression levels of matrix metalloproteinase to E-cadherin in prostate biopsy specimens distinguishes organ-confined from advanced prostate cancer at radical prostatectomy. Clin Cancer Res 9:2185-2194 (Pubitemid 36687642)
18. Gohji K, Fujimoto N, Hara I, Fujii A, Gotoh A, Okada H, Arakawa S, Kitazawa S, Miyake H, Kamidono S, Nakajima M 1998 Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension. Int J Cancer 79:96-101 (Pubitemid 28157734)
19. Daja MM, Niu X, Zhao Z, Brown JM, Russell PJ 2003 Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines. Prostate Cancer Prostatic Dis 6:15-26 (Pubitemid 36432616)
20. Wilson MJ, SellersRG,Wiehr C,MelamudO, Pei D, Peehl DM 2002 Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells. J Cell Physiol 191:208-216 (Pubitemid 34273469)
21. Zhang J, Jung K, Lein M, Kristiansen G, Rudolph B, Hauptmann S, Schnorr D, Loening SA, Lichtinghagen R 2002 Differential expression of matrix metalloproteinases and their tissue inhibitors in human primary cultured prostatic cells and malignant prostate cell lines. Prostate 50:38-45 (Pubitemid 34044863)
22. Littlepage LE, Sternlicht MD, Rougier N, Phillips J, Gallo E, Yu Y, Williams K, Brenot A, Gordon JI, Werb Z 2010 Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. Cancer Res 70:2224-2234
23. Song RX, Zhang Z, Chen Y, Bao Y, Santen RJ 2007 Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells. Endocrinology 148:4091-4101 (Pubitemid 47105855)
24. Russo LA, Peano BJ, Trivedi SP, Cavalcanto TD, Olenchock BA, Caruso JA, Smolock AR, Vishnevsky O, Gardner RM 2009 Regulated expression of matrix metalloproteinases, inflammatory mediators, and endometrial matrix remodeling by 17beta-estradiol in the immature rat uterus. Reprod Biol Endocrinol 7:124
25. Grandas OH, Mountain DH, Kirkpatrick SS, Cassada DC, Stevens SL, Freeman MB, Goldman MH 2009 Regulation of vascular smooth muscle cell expression and function of matrix metalloproteinases is mediated by estrogen and progesterone exposure. J Vasc Surg 49:185-191
26. Huang X, Chen S, Xu L, Liu Y, Deb DK, Platanias LC, Bergan RC 2005 Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells. Cancer Res 65:3470-3478 (Pubitemid 40524634)
27. Zhang J, Hess MW, Thurnher M, Hobisch A, Radmayr C, Cronauer MV, Hittmair A, Culig Z, Bartsch G, Klocker H 1997 Human prostatic smooth muscle cells in culture: estradiol enhances expression of smooth muscle cell-specific markers. Prostate 30:117-129
28. Webber MM, Trakul N, Thraves PS, Bello-DeOcampo D, Chu WW, Storto PD, Huard TK, Rhim JS, Williams DE 1999 A human prostatic stromal myofibroblast cell line WPMY-1: a model for stromal-epithelial interactions in prostatic neoplasia. Carcinogenesis 20:1185-1192 (Pubitemid 29341437)
29. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL 2000 Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275:36803-36810 (Pubitemid 32002090)
30. Zhang L, Wang CY, Yang R, Shi J, Fu R, Chen L, Klocker H, Zhang J 2008 Real-time quantitative RT-PCR assay of prostate-specific antigen and prostate-specific membrane antigen in peripheral blood for detection of prostate cancer micrometastasis. Urol Oncol 26: 634-640
31. Wang CY, Shi JD, Yan CH,WuQ, Klocker H, Park I, Lee C, Zhang J 2007 Development of a cell-isolation method for human prostatic smooth muscle cells based on cell type-specific activation of the SM22 gene promoter. BJU Int 99:183-188 (Pubitemid 44915644)
32. Wu Q, Zhou Y, Chen L, Shi J, Wang CY, Miao L, Klocker H, Park I, Lee C, Zhang J 2007 Benign prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2. J Endocrinol 195:89-94 (Pubitemid 350056002)
33. Wu Q, Shi J, Chen L, Wang CY, Park I, Lee C, Zhang J 2008 Regulation of proliferation and differentiation of prostatic stromal cells by oestradiol through prostatic epithelial cells in a paracrine manner. BJU Int 101:497-502 (Pubitemid 351160939)
34. Miao L, Shi J, Wang CY, Zhu Y, Du X, Jiao H, Mo Z, Klocker H, Lee C, Zhang J 2010 Estrogen receptor-related receptor alpha mediates up-regulation of aromatase expression by prostaglandin E2 in prostate stromal cells. Mol Endocrinol 24:1175-1186
35. Lechapt-Zalcman E, Pruliere-Escabasse V, Advenier D, Galiacy S, Charriere-Bertrand C, Coste A, Harf A, d'Ortho MP, Escudier E 2006 Transforming growth factor-beta1 increases airway wound repair via MMP-2 upregulation: a new pathway for epithelial wound repair? Am J Physiol Lung Cell Mol Physiol 290:L1277-L1282
36. Xu L, Bergan RC 2006 Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway. Mol Pharmacol 70:869-877 (Pubitemid 44268444)
37. Li SC, Chen GF, Chan PS, Choi HL, Ho SM, Chan FL 2001 Altered expression of extracellular matrix and proteinases in Noble rat prostate gland after long-term treatment with sex steroids. Prostate 49: 58-71
38. Zhou W, Park I, Pins M, Kozlowski JM, Jovanovic B, Zhang J, Lee C, Ilio K 2003 Dual regulation of proliferation and growth arrest in prostatic stromal cells by transforming growth factor-beta1. Endocrinology 144:4280-4284 (Pubitemid 37204825)
39. Tomlinson DC, Freestone SH, Grace OC, Thomson AA 2004 Differential effects of transforming growth factor-beta1 on cellular proliferation in the developing prostate. Endocrinology 145:4292-4300 (Pubitemid 39120579)
40. De Wever O, Demetter P, Mareel M, Bracke M 2008 Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 123: 2229-2238